华恒生物：第四届董事会第二十三次会议决议公告

Core Viewpoint - Huaheng Biological announced the approval of multiple proposals, including the issuance of H-shares and listing on the Hong Kong Stock Exchange during the 23rd meeting of its fourth board of directors [2] Group 1 - The company has passed a resolution to issue H-shares [2] - The listing will take place on the Hong Kong Stock Exchange [2]